319 related articles for article (PubMed ID: 26298439)
1. Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis.
Alonso M; Gutzman A; Mazin R; Pinzon CE; Reveiz L; Ghidinelli M
Int J Public Health; 2015 Nov; 60(7):789-98. PubMed ID: 26298439
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
3. The changing face of HIV in Latin America and the Caribbean.
García PJ; Bayer A; Cárcamo CP
Curr HIV/AIDS Rep; 2014 Jun; 11(2):146-57. PubMed ID: 24824881
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.
Tengan FM; Ibrahim KY; Dantas BP; Manchiero C; Magri MC; Bernardo WM
BMC Infect Dis; 2016 Nov; 16(1):663. PubMed ID: 27829381
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis C virus infection among key populations in China: A systematic review.
Liu CR; Li X; Chan PL; Zhuang H; Jia JD; Wang X; Lo YR; Walsh N
Int J Infect Dis; 2019 Mar; 80():16-27. PubMed ID: 30529371
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Among People Who Inject Drugs (PWID) in Latin America and the Caribbean: A Meta-Analysis of Prevalence Over Three Decades.
Magri MC; Manchiero C; Dantas BP; da Silva Nunes AK; Vaz Gago Prata T; Domingos DEA; Dos Santos Nascimento G; Alvarez MSM; Bernardo WM; Tengan FM
J Stud Alcohol Drugs; 2023 Jan; 84(1):118-127. PubMed ID: 36799682
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
9. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
[TBL] [Abstract][Full Text] [Related]
10. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.
Vescio MF; Longo B; Babudieri S; Starnini G; Carbonara S; Rezza G; Monarca R
J Epidemiol Community Health; 2008 Apr; 62(4):305-13. PubMed ID: 18339822
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and burden of hepatitis C virus infection in WHO South-East Asia Region: A systematic review.
Goel A; Rewari BB; Sharma M; Konath NM; Aggarwal R
J Gastroenterol Hepatol; 2022 Jun; 37(6):964-972. PubMed ID: 35263807
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs.
Buffington J; Murray PJ; Schlanger K; Shih L; Badsgard T; Hennessy RR; Wood R; Weisfuse IB; Gunn RA
Public Health Rep; 2007; 122 Suppl 2(Suppl 2):63-7. PubMed ID: 17542456
[TBL] [Abstract][Full Text] [Related]
15. Syphilis in the most at-risk populations in Latin America and the Caribbean: a systematic review.
Zoni AC; González MA; Sjögren HW
Int J Infect Dis; 2013 Feb; 17(2):e84-92. PubMed ID: 23063547
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis C virus infection among high-risk groups in Iran: a systematic review and meta-analysis.
Nematollahi S; Ayubi E; Almasi-Hashiani A; Mansori K; Moradi Y; Veisani Y; Jenabi E; Gholamaliei B; Khazaei S
Public Health; 2018 Aug; 161():90-98. PubMed ID: 29935474
[TBL] [Abstract][Full Text] [Related]
17. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Rodríguez-Ramírez S; Sierra-Madero J; Beyrer C
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of HIV in Latin America and the Caribbean.
De Boni R; Veloso VG; Grinsztejn B
Curr Opin HIV AIDS; 2014 Mar; 9(2):192-8. PubMed ID: 24356327
[TBL] [Abstract][Full Text] [Related]
19. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B in people living with HIV/AIDS in Latin America and the Caribbean: a systematic review and meta-analysis.
Tengan FM; Abdala E; Nascimento M; Bernardo WM; Barone AA
BMC Infect Dis; 2017 Aug; 17(1):587. PubMed ID: 28836955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
